Is the current guidelines’ recommendation of moderate exercise for 150 minutes per week during pregnancy enough to reduce the risk of gestational diabetes? 

Examining how curcumin and other bioactive compounds in turmeric lower blood glucose.

By Sheri Colberg, PhD
I recently was asked about the latest research on the reversal of type 2 diabetes—both bariatric and non-bariatric solutions—and it made me wonder about the mechanisms of this possibility and what role being active may play in it. Each new year always brings a whole host of resolutions that people make focused on losing weight, getting more fit, and becoming healthier. Especially with all the COVID-related pounds I have heard about people gaining, I expect these resolutions to be out in full force at the start of 2022. But how effective will they be long-term, and is the reversal of type 2 diabetes a realistic resolution to make?

Sodium-glucose cotransporter 2 (SGLT2) inhibitors were created to treat diabetes, but noted to ameliorate cardiovascular events. 

Health plans with high deductibles require thousands of dollars out-of-pocket and have a known association with delays in treatment; a repeated cross-sectional study found they are also associated with medication non-adherence.

The case for why an SGLT2 inhibitor or GLP-1 receptor agonist should be initiated early in diabetes treatment, regardless of whether the patient is on insulin therapy.

Artificial intelligence fingerprints gut flora, linking clusters of microbial species with type 1 diabetes development.

DPP4 inhibitors may restore the normal functioning of vascular endothelium in patients who require insulin treatment. 

Researchers showed that elevated blood pressure is a modifiable risk factor for new-onset type 2 diabetes.

The mean age at diagnosis of diabetes for non-Hispanic Black and Hispanic adults was 4-7 years earlier than for non-Hispanic white adults.